World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page
Cell donors are essential for new therapies. They need to be taken care of

Cell donors are essential for new therapies. They need to be taken care of

by admin | Aug 8, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Priya Baraniak – STAT News – Cutting-edge FDA-approved therapies made from human cells are now being used to treat cancer, diabetes, and other diseases. Currently, most approved cell-based therapies use an individual’s own cells, but the next generation...
New study shows ‘dancing molecules’ can regenerate cartilage in 3 days

New study shows ‘dancing molecules’ can regenerate cartilage in 3 days

by admin | Aug 7, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Medical Xpress News – In November 2021, Northwestern University researchers introduced an injectable new therapy, which harnessed fast-moving “dancing molecules,” to repair tissues and reverse paralysis after severe spinal cord injuries. Now, the...
DA Grants Regenerative Medicine Advanced Therapy Designation for AIC100 to Treat Thyroid Cancer

DA Grants Regenerative Medicine Advanced Therapy Designation for AIC100 to Treat Thyroid Cancer

by admin | Aug 6, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Kennedy Ferruggia – Pharmacy Times – The FDA has granted regenerative medicine advanced therapy (RMAT) designation for AIC100 (Affylmmune Therapeutics), an ICAM-1 targeting and affinity-tuned LFA-1 binder chimeric antigen receptor (CAR) T-cell therapy...
Deciphering the journey from stem cells to neurons

Deciphering the journey from stem cells to neurons

by admin | Aug 5, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Riken Research News – RIKEN researchers have uncovered how gradual changes in gene-expression patterns drive a cell-fate switch in neural stem cells (NSCs) in mice1. All the major neuronal types of cells in the central nervous system are created through the...
Fighting leukaemia by targeting its stem cells

Fighting leukaemia by targeting its stem cells

by admin | Aug 2, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By University of Geneva – Acute myeloid leukaemia is one of the deadliest cancers. Leukaemic stem cells responsible for the disease are highly resistant to treatment. A team from the University of Geneva (UNIGE), University Hospital of Geneva (HUG), and Inserm...
Gene variant slows form of inherited Alzheimer’s disease

Gene variant slows form of inherited Alzheimer’s disease

by admin | Aug 1, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By NIH Research Matters – Variations in certain genes can modify the risk of developing Alzheimer’s disease (AD) and other types of dementia. Some of the best understood variants to date are in a gene called APOE. This gene plays a role in the transport of...
Page 53 of 191« First«...102030...5152535455...607080...»Last »

Recent Posts

  • CAR NK cell therapy clinical trial puts follicular lymphoma survivor into remission
  • Stem cell therapy linked to lower risk of heart failure after a heart attack
  • Embryo-Like ‘Blood Factories’ Could One Day Supplement Donations
  • Long-Term Growth Hormone Therapy Boosts Pediatric Stem Cells
  • New UCLA drug could restore heart and organ function
  • Parkinson’s treatment tested at UW showing promise in first clinical trial
World Stem Cell Summit Logo - White version
Copyright © 2025 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow